This bidirectionality BPC-157 can both activate NO production in ischemic/hypoxic tissue and normalize NO dysregulation in inflammatory conditions suggests that the compound does not simply "increase" or "decrease" NO
I found 34 papers that commented on safety, asserting BPC-157 to be safe, well-tolerated, or harmless. Sikirics group has actually claimed that the LD1 dose has not been achieved, essentially asserting that no reasonable quantity of BPC-157 even could be harmful
HUBERMAN: So if you have a tumor someplace and it's small, taking exogenous growth hormone or increasing the amount of growth hormone that you release by taking one of these peptides that we discussed will increase the size of that tumor
But what exactly are peptides, and why are so many locals turning to them for better energy, faster recovery, and healthier aging
Dosing & Reconstitution Guide CagriSema is titrated slowly because gastrointestinal tolerability not peak effect is the limiting factor, and it stacks two appetite-signaling peptides that each act on gut motility
